Found 22 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet 
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | 1.26E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP2D6 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | 6.31E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 1A2
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP1A2 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C19 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP3A4 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP2D6 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C19 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP2C9 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 1A2
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Inhibition of CYP1A2 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | >5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Time dependent inhibition of CYP3A4 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | >5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Time dependent inhibition of CYP2C19 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 1A2
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | >5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Time dependent inhibition of CYP1A2 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 1A2
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Time dependent inhibition of CYP1A2 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | >5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Time dependent inhibition of CYP2D6 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Time dependent inhibition of CYP2C19 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Time dependent inhibition of CYP3A4 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | >5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Time dependent inhibition of CYP2C9 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
MMDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Time dependent inhibition of CYP2C9 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | >5.01E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Time dependent inhibition of CYP2D6 |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Nuclear receptor subfamily 1 group I member 2
(Homo sapiens (Human)) | BDBM50419279
(CHEMBL1835918)Show InChI InChI=1S/C18H19N5O2/c1-12-3-8-17(21-20-12)23-9-14(10-23)11-24-16-6-4-15(5-7-16)18-19-13(2)25-22-18/h3-8,14H,9-11H2,1-2H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | n/a | n/a | 3.16E+4 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Activation of human PXR expressed in african green monkey CV1 cells transfected with pSG5-hPXRDATG and (ER6)3-tk-CAT reporter |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Nuclear receptor subfamily 1 group I member 2
(Homo sapiens (Human)) | BDBM50111469
(3-(3,5-dimethyl-4-(3-(3-methylisoxazol-5-yl)propox...)Show SMILES Cc1cc(CCCOc2c(C)cc(cc2C)-c2noc(n2)C(F)(F)F)on1 Show InChI InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
MMDB
PC cid
PC sid
PDB
UniChem
Patents
| Article
PubMed
| n/a | n/a | n/a | n/a | 251 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description
Activation of human PXR expressed in african green monkey CV1 cells transfected with pSG5-hPXRDATG and (ER6)3-tk-CAT reporter |
Bioorg Med Chem Lett 21: 6031-5 (2011)
Article DOI: 10.1016/j.bmcl.2011.08.083
BindingDB Entry DOI: 10.7270/Q2NV9KH9 |
More data for this
Ligand-Target Pair | |
Search and Browse
